HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC

The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in e...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 5; no. 5; p. e1000414
Main Authors Wood, Natasha, Bhattacharya, Tanmoy, Keele, Brandon F., Giorgi, Elena, Liu, Michael, Gaschen, Brian, Daniels, Marcus, Ferrari, Guido, Haynes, Barton F., McMichael, Andrew, Shaw, George M., Hahn, Beatrice H., Korber, Bette, Seoighe, Cathal
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.05.2009
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1553-7374
1553-7366
1553-7374
DOI10.1371/journal.ppat.1000414

Cover

Abstract The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections.
AbstractList The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n=78) or two closely related viruses (n=3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections.
The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections. Author Summary HIV is a rapidly evolving virus, displaying enormous genetic diversity between and even within infected individuals, with implications for vaccine design and drug treatment. Yet, recent research has shown that most new infections result from transmission of a single virus resulting in a homogeneous viral population in early infection. The process of diversification from the transmitted virus provides information about the selection pressures experienced by the virus during the establishment of a new infection. In this paper, we studied early diversification of the envelope gene in a cohort of 81 subjects acutely infected with HIV-1 subtype B and found evidence of adaptive evolution, with a proportion of sites that tended to diversify more rapidly than expected under a model of neutral evolution. Several of these rapidly diversifying sites facilitate escape from early cytotoxic immune responses. Interestingly, hypermutation of the virus, brought about by host proteins as a strategy to restrict infection, appeared to be associated with early immune escape. In addition to single base substitutions, insertions and deletions are an important aspect of HIV evolution. We show that insertion and deletion mutations occur evenly across the gene, but are preferentially fixed in the variable loop regions.
The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections. HIV is a rapidly evolving virus, displaying enormous genetic diversity between and even within infected individuals, with implications for vaccine design and drug treatment. Yet, recent research has shown that most new infections result from transmission of a single virus resulting in a homogeneous viral population in early infection. The process of diversification from the transmitted virus provides information about the selection pressures experienced by the virus during the establishment of a new infection. In this paper, we studied early diversification of the envelope gene in a cohort of 81 subjects acutely infected with HIV-1 subtype B and found evidence of adaptive evolution, with a proportion of sites that tended to diversify more rapidly than expected under a model of neutral evolution. Several of these rapidly diversifying sites facilitate escape from early cytotoxic immune responses. Interestingly, hypermutation of the virus, brought about by host proteins as a strategy to restrict infection, appeared to be associated with early immune escape. In addition to single base substitutions, insertions and deletions are an important aspect of HIV evolution. We show that insertion and deletion mutations occur evenly across the gene, but are preferentially fixed in the variable loop regions.
The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections.The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections.
  The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced by the newly transmitted virus. For example, sites that tend to evolve rapidly across multiple early-infection patients could be involved in enabling escape from common early immune responses, could represent adaptation for rapid growth in a newly infected host, or could represent reversion from less fit forms of the virus that were selected for immune escape in previous hosts. Here we investigated the diversification of HIV-1 env coding sequences in 81 very early B subtype infections previously shown to have resulted from transmission or expansion of single viruses (n = 78) or two closely related viruses (n = 3). In these cases, the sequence of the infecting virus can be estimated accurately, enabling inference of both the direction of substitutions as well as distinction between insertion and deletion events. By integrating information across multiple acutely infected hosts, we find evidence of adaptive evolution of HIV-1 env and identify a subset of codon sites that diversified more rapidly than can be explained by a model of neutral evolution. Of 24 such rapidly diversifying sites, 14 were either i) clustered and embedded in CTL epitopes that were verified experimentally or predicted based on the individual's HLA or ii) in a nucleotide context indicative of APOBEC-mediated G-to-A substitutions, despite having excluded heavily hypermutated sequences prior to the analysis. In several cases, a rapidly evolving site was embedded both in an APOBEC motif and in a CTL epitope, suggesting that APOBEC may facilitate early immune escape. Ten rapidly diversifying sites could not be explained by CTL escape or APOBEC hypermutation, including the most frequently mutated site, in the fusion peptide of gp41. We also examined the distribution, extent, and sequence context of insertions and deletions, and we provide evidence that the length variation seen in hypervariable loop regions of the envelope glycoprotein is a consequence of selection and not of mutational hotspots. Our results provide a detailed view of the process of diversification of HIV-1 following transmission, highlighting the role of CTL escape and hypermutation in shaping viral evolution during the establishment of new infections.
Audience Academic
Author McMichael, Andrew
Keele, Brandon F.
Ferrari, Guido
Wood, Natasha
Gaschen, Brian
Hahn, Beatrice H.
Korber, Bette
Seoighe, Cathal
Liu, Michael
Daniels, Marcus
Giorgi, Elena
Shaw, George M.
Bhattacharya, Tanmoy
Haynes, Barton F.
AuthorAffiliation 9 School of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland
3 Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America
7 Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
5 University of Alabama at Birmingham, Birmingham, Alabama, United States of America
NIH/NIAID, United States of America
1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa
4 Santa Fe Institute, Santa Fe, New Mexico, United States of America
6 Department of Mathematics and Statistics, University of Massachusetts, Amherst, Massachusetts, United States of America
8 Duke University, Durham, North Carolina, United States of America
2 Centre for High-Performance Computing, CSIR Campus, Rosebank, Cape Town, South Africa
AuthorAffiliation_xml – name: 1 Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa
– name: 8 Duke University, Durham, North Carolina, United States of America
– name: 6 Department of Mathematics and Statistics, University of Massachusetts, Amherst, Massachusetts, United States of America
– name: 9 School of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland
– name: 2 Centre for High-Performance Computing, CSIR Campus, Rosebank, Cape Town, South Africa
– name: 3 Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America
– name: 5 University of Alabama at Birmingham, Birmingham, Alabama, United States of America
– name: 4 Santa Fe Institute, Santa Fe, New Mexico, United States of America
– name: 7 Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
– name: NIH/NIAID, United States of America
Author_xml – sequence: 1
  givenname: Natasha
  surname: Wood
  fullname: Wood, Natasha
– sequence: 2
  givenname: Tanmoy
  surname: Bhattacharya
  fullname: Bhattacharya, Tanmoy
– sequence: 3
  givenname: Brandon F.
  surname: Keele
  fullname: Keele, Brandon F.
– sequence: 4
  givenname: Elena
  surname: Giorgi
  fullname: Giorgi, Elena
– sequence: 5
  givenname: Michael
  surname: Liu
  fullname: Liu, Michael
– sequence: 6
  givenname: Brian
  surname: Gaschen
  fullname: Gaschen, Brian
– sequence: 7
  givenname: Marcus
  surname: Daniels
  fullname: Daniels, Marcus
– sequence: 8
  givenname: Guido
  surname: Ferrari
  fullname: Ferrari, Guido
– sequence: 9
  givenname: Barton F.
  surname: Haynes
  fullname: Haynes, Barton F.
– sequence: 10
  givenname: Andrew
  surname: McMichael
  fullname: McMichael, Andrew
– sequence: 11
  givenname: George M.
  surname: Shaw
  fullname: Shaw, George M.
– sequence: 12
  givenname: Beatrice H.
  surname: Hahn
  fullname: Hahn, Beatrice H.
– sequence: 13
  givenname: Bette
  surname: Korber
  fullname: Korber, Bette
– sequence: 14
  givenname: Cathal
  surname: Seoighe
  fullname: Seoighe, Cathal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19424423$$D View this record in MEDLINE/PubMed
https://www.osti.gov/servlets/purl/1627892$$D View this record in Osti.gov
BookMark eNqVk-9r1DAYx4tM3A_9D0TLBEHYnUnaJO1eCOd5usJwh1PfhjRN7nL0kjNJh_vvTa-3sRNRpNAmTz_PN0--PM9xcmCskUnyHIIxzCh8u7KdM7wdbzY8jCEAIIf5o-QIYpyNaEbzgwfrw-TY-1WPZJA8SQ5hmaM8R9lR4i-q7-nsxrZd0Nak2qQz7trbtDJKij50nl7Ldlimcye97-LrLJ3zEKQzPrUqsl66LcBNk36IeL852-7CUqbVesNF6MnJ_Or9bPo0eax46-Wz3fck-fZx9nV6Mbq8-lRNJ5cjQTEOI6VwndGaZxAihZQSuFQUiIbSnDRENITDWuWYA4w4F7hBCAGgiCxxWVOIYHaSvBx0N631bOeXZxAVJcAFIFkkqoFoLF-xjdNr7m6Z5ZptA9YtGI83E61kgigkAYEF4tE5IEpQZ5iWRZPlpaBURq13u9O6ei0bIU1wvN0T3f9j9JIt7A1DhMIiJ1HgdBCwPmjmhQ5SLIU1JrrPIEG0KFGEXu9OcfZHJ31ga-2FbFtupO08IxShEkLwTxABQgq8denVAC54vKY2ysbqRA-zCQKQgDLqRWr8Byo-jVzrWKRUOsb3Et7sJUQmyJ9hwTvvWXX95T_Yz_vsi4c23_t719IROB8A4az3TioWneR9R8aKdcsgYP383PUD6-eH7eYnJue_Jd_r_y3tF685HYw
CitedBy_id crossref_primary_10_1016_j_jmb_2017_05_010
crossref_primary_10_1016_j_jmb_2013_10_033
crossref_primary_10_1126_science_abd2638
crossref_primary_10_1128_JVI_01223_10
crossref_primary_10_1097_QAD_0b013e32835cab64
crossref_primary_10_1371_journal_pone_0027098
crossref_primary_10_1093_molbev_msae109
crossref_primary_10_1371_journal_ppat_1001228
crossref_primary_10_2139_ssrn_3155699
crossref_primary_10_1093_ve_veae108
crossref_primary_10_1371_journal_ppat_1002721
crossref_primary_10_1371_journal_pone_0071888
crossref_primary_10_1093_gbe_evab097
crossref_primary_10_1186_1742_4690_8_77
crossref_primary_10_1016_j_virol_2012_08_028
crossref_primary_10_1093_annonc_mdy003
crossref_primary_10_1093_ve_vey007
crossref_primary_10_1038_mt_2009_316
crossref_primary_10_1186_s12981_017_0173_8
crossref_primary_10_1093_ve_vev015
crossref_primary_10_3390_v12060587
crossref_primary_10_1099_vir_0_000214
crossref_primary_10_1111_j_1365_3083_2011_02602_x
crossref_primary_10_1371_journal_ppat_1008381
crossref_primary_10_1002_cmdc_201200411
crossref_primary_10_1016_j_virusres_2016_12_019
crossref_primary_10_1371_journal_pbio_1001466
crossref_primary_10_1016_j_bbagen_2019_04_011
crossref_primary_10_1016_j_str_2014_03_014
crossref_primary_10_1007_s00430_011_0199_9
crossref_primary_10_1097_COH_0000000000000040
crossref_primary_10_1371_journal_pone_0012303
crossref_primary_10_1128_JVI_00313_11
crossref_primary_10_1371_journal_ppat_1000890
crossref_primary_10_1186_1742_4690_9_35
crossref_primary_10_24072_pcjournal_6
crossref_primary_10_1371_journal_ppat_1006510
crossref_primary_10_1128_jvi_01635_22
crossref_primary_10_1371_journal_ppat_1004453
crossref_primary_10_1128_JVI_00062_14
crossref_primary_10_3390_v6093612
crossref_primary_10_1128_JVI_02587_12
crossref_primary_10_1172_JCI86047
crossref_primary_10_1073_pnas_1402285111
crossref_primary_10_1155_2013_683095
crossref_primary_10_1021_acsptsci_1c00091
crossref_primary_10_1111_imr_12688
crossref_primary_10_1186_1471_2105_11_532
crossref_primary_10_1093_infdis_jis503
crossref_primary_10_1111_mmi_12065
crossref_primary_10_1371_journal_ppat_1005254
crossref_primary_10_1016_j_immuni_2012_08_010
crossref_primary_10_1371_journal_pcbi_1005094
crossref_primary_10_1371_journal_ppat_1004281
crossref_primary_10_1097_QAI_0000000000000689
crossref_primary_10_1111_j_1365_3083_2012_02696_x
crossref_primary_10_1128_JVI_02697_10
crossref_primary_10_1016_j_chom_2021_05_012
crossref_primary_10_1021_acsinfecdis_7b00221
crossref_primary_10_1038_s41576_022_00459_8
crossref_primary_10_1186_1742_4690_9_54
crossref_primary_10_1371_journal_pone_0093428
crossref_primary_10_3390_v13071366
crossref_primary_10_1084_jem_20090378
crossref_primary_10_7717_peerj_3391
crossref_primary_10_1371_journal_ppat_1005646
crossref_primary_10_1097_COH_0b013e328361cfff
crossref_primary_10_1186_s12977_018_0457_7
crossref_primary_10_1128_JVI_00823_10
crossref_primary_10_3390_v16111697
crossref_primary_10_1097_QAD_0b013e328353bcaf
crossref_primary_10_1186_s12977_017_0367_0
crossref_primary_10_1093_molbev_msz155
crossref_primary_10_1128_JVI_01862_12
crossref_primary_10_1097_QAI_0b013e3182986f96
crossref_primary_10_1155_2012_508967
crossref_primary_10_1128_JVI_01460_14
crossref_primary_10_1016_j_virol_2015_03_012
crossref_primary_10_3390_v5102349
crossref_primary_10_1021_acs_biochem_8b00858
crossref_primary_10_1371_journal_pgen_1004761
crossref_primary_10_1016_j_meegid_2011_04_020
crossref_primary_10_1016_j_virol_2012_03_008
crossref_primary_10_3389_fgene_2022_875406
crossref_primary_10_1016_j_virol_2009_12_030
crossref_primary_10_1371_journal_ppat_1002800
crossref_primary_10_3390_v15122424
crossref_primary_10_1016_j_virusres_2014_03_019
crossref_primary_10_1186_1742_4690_9_112
crossref_primary_10_1093_ve_vey040
crossref_primary_10_4049_jimmunol_1201184
crossref_primary_10_1016_j_cels_2021_09_013
crossref_primary_10_1097_QAD_0b013e32835461b5
crossref_primary_10_1128_JVI_00157_18
crossref_primary_10_1038_nrmicro3449
crossref_primary_10_1371_journal_pone_0139037
crossref_primary_10_1371_journal_pone_0033502
crossref_primary_10_1021_acs_biochem_2c00188
crossref_primary_10_1128_JVI_01543_19
crossref_primary_10_1111_j_1365_2567_2010_03294_x
crossref_primary_10_1016_j_virol_2013_11_026
crossref_primary_10_1093_ve_vez022
crossref_primary_10_1016_j_jtbi_2011_03_011
crossref_primary_10_1093_infdis_jis411
crossref_primary_10_1097_QAD_0b013e32835cffd9
crossref_primary_10_1371_journal_pone_0035491
crossref_primary_10_3390_v4113132
crossref_primary_10_1016_j_jbiotec_2016_03_038
crossref_primary_10_1007_s10096_018_3235_5
crossref_primary_10_1371_journal_pone_0012631
crossref_primary_10_1128_JVI_06157_11
crossref_primary_10_3389_fimmu_2018_03032
crossref_primary_10_1371_journal_pone_0076002
crossref_primary_10_1186_1479_5876_9_212
crossref_primary_10_1128_JVI_00383_15
crossref_primary_10_1080_08830185_2017_1403596
crossref_primary_10_1038_mi_2011_12
crossref_primary_10_1017_S1462399409001343
crossref_primary_10_1089_aid_2011_0208
crossref_primary_10_1371_journal_pone_0070814
crossref_primary_10_1016_j_jtbi_2013_03_026
crossref_primary_10_1093_ve_veaa089
crossref_primary_10_1038_mt_2012_107
crossref_primary_10_1128_jvi_02011_21
crossref_primary_10_3389_fmicb_2014_00534
crossref_primary_10_1093_ve_vey029
crossref_primary_10_1128_JVI_00495_16
crossref_primary_10_1097_COH_0b013e32833a0b9b
crossref_primary_10_4049_jimmunol_1600343
crossref_primary_10_1089_aid_2011_0291
crossref_primary_10_1371_journal_pone_0032714
crossref_primary_10_1099_vir_0_055335_0
crossref_primary_10_1111_j_1601_183X_2011_00752_x
crossref_primary_10_1097_COH_0b013e32832d9fef
crossref_primary_10_1128_JVI_02939_15
crossref_primary_10_3390_vaccines11020472
crossref_primary_10_1107_S139900471401267X
crossref_primary_10_1371_journal_pgen_1002550
crossref_primary_10_1371_journal_pcbi_1009878
crossref_primary_10_1128_JVI_01705_14
crossref_primary_10_1371_journal_pone_0069029
crossref_primary_10_1371_journal_ppat_1002209
crossref_primary_10_1371_journal_ppat_1005689
crossref_primary_10_1016_S0929_6646_11_60053_3
crossref_primary_10_1016_j_ymeth_2010_05_010
Cites_doi 10.1126/science.280.5371.1884
10.1128/JVI.80.2.999-1014.2006
10.1073/pnas.0700666104
10.1056/NEJMra066267
10.4049/jimmunol.176.10.6130
10.1093/bioinformatics/btl057
10.1126/science.1131528
10.1126/science.288.5472.1789
10.1084/jem.20040511
10.1111/j.1600-065X.1997.tb01004.x
10.1126/science.1093137
10.1128/JVI.79.9.5721-5731.2005
10.1073/pnas.0936926100
10.1097/00002030-200309050-00005
10.1021/bi990654o
10.1038/nm998
10.1093/genetics/164.3.1229
10.1093/glycob/cwh106
10.1128/JVI.78.13.7069-7078.2004
10.1016/j.virol.2005.04.015
10.1128/JVI.77.8.5037-5038.2003
10.1097/QAD.0b013e32805e8727
10.1038/nm992
10.1073/pnas.1530509100
10.1126/science.283.5403.857
10.1093/oxfordjournals.molbev.a026236
10.1080/10635150390235520
10.1128/JVI.79.10.6528-6531.2005
10.1534/genetics.104.031153
10.1038/nm0297-212
10.1038/35073658
10.1128/JVI.69.8.5087-5094.1995
10.1128/JVI.02660-07
10.1073/pnas.87.16.6024
10.1128/JVI.78.24.13901-13910.2004
10.1016/S0969-2126(98)00096-3
10.1093/oxfordjournals.molbev.a004010
10.1128/JVI.01231-06
10.1093/molbev/msi097
10.1128/JVI.80.4.1637-1644.2006
10.1093/bib/bbn049
10.1093/bioinformatics/bti079
10.1038/sj.emboj.7601358
10.1371/journal.ppat.0040012
10.1128/JVI.80.10.4717-4728.2006
10.1017/S0016672303006128
10.1128/JVI.00141-06
10.1128/JVI.00239-07
10.1002/sim.3192
10.1128/JVI.79.10.6523-6527.2005
10.1038/nrmicro1235
10.1073/pnas.0505126102
10.1038/31514
10.1093/molbev/msl051
10.1128/JVI.02763-06
10.1038/35036559
10.1093/genetics/148.3.929
10.1371/journal.ppat.1000033
10.1128/JVI.79.21.13239-13249.2005
10.1007/s00239-003-2467-9
ContentType Journal Article
Copyright COPYRIGHT 2009 Public Library of Science
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. 2009
2009 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Citation: Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, et al. (2009) HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC. PLoS Pathog 5(5): e1000414. doi:10.1371/journal.ppat.1000414
Copyright_xml – notice: COPYRIGHT 2009 Public Library of Science
– notice: This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. 2009
– notice: 2009 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Citation: Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, et al. (2009) HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC. PLoS Pathog 5(5): e1000414. doi:10.1371/journal.ppat.1000414
CorporateAuthor Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
CorporateAuthor_xml – name: Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISN
ISR
7T5
7U9
H94
7X8
OIOZB
OTOTI
5PM
DOA
DOI 10.1371/journal.ppat.1000414
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Canada
Gale In Context: Science
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
OSTI.GOV - Hybrid
OSTI.GOV
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate HIV Evolution in Early Infection
EISSN 1553-7374
EndPage e1000414
ExternalDocumentID 1289058063
oai_doaj_org_article_c6f2e06182a4420c90b35798d349c77e
PMC2671846
1627892
A201609911
19424423
10_1371_journal_ppat_1000414
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U19 AI067854
– fundername: Medical Research Council
  grantid: MC_U137884177
– fundername: NIAID NIH HHS
  grantid: P30 AI027767
– fundername: NIAID NIH HHS
  grantid: AI27767
– fundername: NIAID NIH HHS
  grantid: U01 AI067854
– fundername: NIAID NIH HHS
  grantid: AI67854
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MM.
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
QN7
RIG
RNS
RPM
SV3
TR2
TUS
UKHRP
WOW
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PV9
QF4
RZL
WOQ
PMFND
7T5
7U9
H94
7X8
3V.
AAPBV
ABPTK
M~E
OIOZB
OTOTI
PQEST
PQUKI
5PM
ID FETCH-LOGICAL-c755t-ff5b37ba3112f2ffc59f70cd7746d6cd6a1bf45a052aac5d22200f6e959b71213
IEDL.DBID M48
ISSN 1553-7374
1553-7366
IngestDate Sun Oct 01 00:11:21 EDT 2023
Wed Aug 27 01:32:11 EDT 2025
Tue Sep 30 16:55:53 EDT 2025
Mon Jul 10 02:30:38 EDT 2023
Thu Sep 04 19:12:38 EDT 2025
Fri Sep 05 06:45:10 EDT 2025
Tue Jun 17 22:06:45 EDT 2025
Tue Jun 10 21:12:42 EDT 2025
Fri Jun 27 06:01:17 EDT 2025
Fri Jun 27 05:44:29 EDT 2025
Mon Jul 21 05:30:38 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Wed Oct 01 04:25:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c755t-ff5b37ba3112f2ffc59f70cd7746d6cd6a1bf45a052aac5d22200f6e959b71213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
AC52-06NA25396; AI67854; AI27767; 37874
Bill & Melinda Gates Foundation
UAB Center for AIDS Research
National Institutes of Health (NIH)
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Conceived and designed the experiments: BK CS. Performed the experiments: NW ML GF CS. Analyzed the data: NW TB BFK EG BG MD GMS BHH BK CS. Wrote the paper: NW GMS BHH BK CS. Coordinated research: BFH AM.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.ppat.1000414
PMID 19424423
PQID 20668521
PQPubID 23462
ParticipantIDs plos_journals_1289058063
doaj_primary_oai_doaj_org_article_c6f2e06182a4420c90b35798d349c77e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2671846
osti_scitechconnect_1627892
proquest_miscellaneous_67229110
proquest_miscellaneous_20668521
gale_infotracmisc_A201609911
gale_infotracacademiconefile_A201609911
gale_incontextgauss_ISR_A201609911
gale_incontextgauss_ISN_A201609911
pubmed_primary_19424423
crossref_citationtrail_10_1371_journal_ppat_1000414
crossref_primary_10_1371_journal_ppat_1000414
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-05-01
PublicationDateYYYYMMDD 2009-05-01
PublicationDate_xml – month: 05
  year: 2009
  text: 2009-05-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, USA
PublicationTitle PLoS pathogens
PublicationTitleAlternate PLoS Pathog
PublicationYear 2009
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References R Nielsen (ref51) 1998; 148
S Rits-Volloch (ref14) 2006; 25
M Sagar (ref26) 2006; 80
CA Derdeyn (ref20) 2004; 303
JF Salazar-Gonzalez (ref16) 2008; 82
EL Turnbull (ref38) 2006; 176
MJ Root (ref7) 2003; 100
N Goonetilleke (ref64) 2006; 80
SL Kosakovsky Pond (ref18) 2005; 21
CTT Edwards (ref31) 2006; 6
PJR Goulder (ref43) 1997; 3
ES Gray (ref22) 2007; 81
LM Mansky (ref63) 1995; 69
TM Allen (ref45) 2005; 79
S Guindon (ref58) 2003; 52
B Li (ref44) 2007; 81
DR Burton (ref9) 2005; 102
TM Allen (ref42) 2000; 407
FW Peyerl (ref47) 2004; 78
ZH Yang (ref56) 2005; 22
QJ Sattentau (ref6) 1998; 6
N Frahm (ref25) 2008
W Delport (ref53) 2009; 10
BF Keele (ref15) 2008
B Chohan (ref19) 2005; 79
VK Pathak (ref23) 1990; 87
T Bhattacharya (ref59) 2007; 315
JD Storey (ref61) 2003; 100
SDW Frost (ref21) 2005; 79
D Shriner (ref29) 2003; 81
R Wyatt (ref12) 1998; 393
TM Allen (ref48) 2004; 78
MJ Hollier (ref5) 2005; 337
W Yang (ref52) 2003; 57
R Wyatt (ref3) 1998; 280
LS Frost (ref32) 2005; 3
B Asquith (ref33) 2007; 104
AJ Leslie (ref34) 2004; 10
M Bunce (ref65) 2002
JT Herbeck (ref46) 2006; 80
WSW Wong (ref55) 2004; 168
Y Suzuki (ref27) 2002; 19
P Goulder (ref35) 1997; 159
AJ McMichael (ref36) 2001; 410
M Markowitz (ref62) 2003; 77
TC Friedrich (ref2) 2004; 10
WM Blay (ref11) 2006; 80
L Loh (ref40) 2007; 81
SL Kosakovsky Pond (ref50) 2008; 27
ZH Yang (ref54) 2000; 17
MI Johnston (ref8) 2007; 356
NA Jones (ref24) 2004; 200
L Loh (ref41) 2008; 4
N Goldman (ref57) 1994; 11
M Anisimova (ref28) 2003; 164
M Zhang (ref10) 2004; 14
SL Kosakovsky Pond (ref30) 2006; 23
CA Blish (ref4) 2007; 21
DR Chopera (ref1) 2008; 4(3)
JE Schmitz (ref37) 1999; 283
J Maydt (ref49) 2006; 22
B Korber (ref60) 2000; 288
WT Zhang (ref13) 1999; 38
EW Fiebig (ref17) 2003; 17
CS Fernandez (ref39) 2005; 79
References_xml – volume: 280
  start-page: 1884
  year: 1998
  ident: ref3
  article-title: The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens.
  publication-title: Science
  doi: 10.1126/science.280.5371.1884
– volume: 80
  start-page: 999
  year: 2006
  ident: ref11
  article-title: Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.80.2.999-1014.2006
– volume: 104
  start-page: 6365
  year: 2007
  ident: ref33
  article-title: In vivo CD8(+) T cell control of immunodeficiency virus infection in humans and macaques.
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.0700666104
– volume: 356
  start-page: 2073
  year: 2007
  ident: ref8
  article-title: Current concepts: An HIV vaccine - Evolving concepts.
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMra066267
– volume: 176
  start-page: 6130
  year: 2006
  ident: ref38
  article-title: HIV-1 epitope-specific CD8(+) T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.176.10.6130
– volume: 22
  start-page: 1064
  year: 2006
  ident: ref49
  article-title: Recco: recombination analysis using cost optimization.
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btl057
– volume: 315
  start-page: 1583
  year: 2007
  ident: ref59
  article-title: Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
  publication-title: Science
  doi: 10.1126/science.1131528
– volume: 288
  start-page: 1789
  year: 2000
  ident: ref60
  article-title: Timing the ancestor of the HIV-1 pandemic strains.
  publication-title: Science
  doi: 10.1126/science.288.5472.1789
– volume: 200
  start-page: 1243
  year: 2004
  ident: ref24
  article-title: Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
  publication-title: The Journal of Experimental Medicine
  doi: 10.1084/jem.20040511
– volume: 159
  start-page: 17
  year: 1997
  ident: ref35
  article-title: Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.
  publication-title: Immunological Reviews
  doi: 10.1111/j.1600-065X.1997.tb01004.x
– volume: 303
  start-page: 2019
  year: 2004
  ident: ref20
  article-title: Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.
  publication-title: Science
  doi: 10.1126/science.1093137
– volume: 79
  start-page: 5721
  year: 2005
  ident: ref39
  article-title: Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.79.9.5721-5731.2005
– volume: 100
  start-page: 5016
  year: 2003
  ident: ref7
  article-title: Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein.
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.0936926100
– volume: 17
  start-page: 1871
  year: 2003
  ident: ref17
  article-title: Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.
  publication-title: Aids
  doi: 10.1097/00002030-200309050-00005
– volume: 38
  start-page: 9405
  year: 1999
  ident: ref13
  article-title: Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
  publication-title: Biochemistry
  doi: 10.1021/bi990654o
– volume: 10
  start-page: 275
  year: 2004
  ident: ref2
  article-title: Reversion of CTL escape-variant immunodeficiency viruses in vivo.
  publication-title: Nature Medicine
  doi: 10.1038/nm998
– volume: 164
  start-page: 1229
  year: 2003
  ident: ref28
  article-title: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites.
  publication-title: Genetics
  doi: 10.1093/genetics/164.3.1229
– volume: 14
  start-page: 1229
  year: 2004
  ident: ref10
  article-title: Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwh106
– volume: 78
  start-page: 7069
  year: 2004
  ident: ref48
  article-title: Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.78.13.7069-7078.2004
– volume: 337
  start-page: 284
  year: 2005
  ident: ref5
  article-title: The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: An analysis of sequence, structure, and function.
  publication-title: Virology
  doi: 10.1016/j.virol.2005.04.015
– volume: 77
  start-page: 5037
  year: 2003
  ident: ref62
  article-title: A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.77.8.5037-5038.2003
– volume: 21
  start-page: 693
  year: 2007
  ident: ref4
  article-title: HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
  publication-title: Aids
  doi: 10.1097/QAD.0b013e32805e8727
– volume: 10
  start-page: 282
  year: 2004
  ident: ref34
  article-title: HIV evolution: CTL escape mutation and reversion after transmission.
  publication-title: Nature Medicine
  doi: 10.1038/nm992
– volume: 100
  start-page: 9440
  year: 2003
  ident: ref61
  article-title: Statistical significance for genomewide studies.
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.1530509100
– volume: 6
  year: 2006
  ident: ref31
  article-title: Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.
  publication-title: Bmc Evolutionary Biology
– volume: 283
  start-page: 857
  year: 1999
  ident: ref37
  article-title: Control of viremia in simian immunodeficiency virus infection by CD8(+) lymphocytes.
  publication-title: Science
  doi: 10.1126/science.283.5403.857
– volume: 17
  start-page: 32
  year: 2000
  ident: ref54
  article-title: Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models.
  publication-title: Molecular Biology and Evolution
  doi: 10.1093/oxfordjournals.molbev.a026236
– volume: 52
  start-page: 696
  year: 2003
  ident: ref58
  article-title: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.
  publication-title: Systematic Biology
  doi: 10.1080/10635150390235520
– volume: 79
  start-page: 6528
  year: 2005
  ident: ref19
  article-title: Selection for human immunodeficiency virus type I envelope glycosylation variants with shorter V1–V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.79.10.6528-6531.2005
– volume: 168
  start-page: 1041
  year: 2004
  ident: ref55
  article-title: Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites.
  publication-title: Genetics
  doi: 10.1534/genetics.104.031153
– volume: 11
  start-page: 725
  year: 1994
  ident: ref57
  article-title: Codon-Based Model of Nucleotide Substitution for Protein-Coding Dna-Sequences.
  publication-title: Molecular Biology and Evolution
– volume: 3
  start-page: 212
  year: 1997
  ident: ref43
  article-title: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
  publication-title: Nature Medicine
  doi: 10.1038/nm0297-212
– volume: 410
  start-page: 980
  year: 2001
  ident: ref36
  article-title: Cellular immune responses to HIV.
  publication-title: Nature
  doi: 10.1038/35073658
– volume: 69
  start-page: 5087
  year: 1995
  ident: ref63
  article-title: Lower In-Vivo Mutation-Rate of Human-Immunodeficiency-Virus Type-1 Than That Predicted from the Fidelity of Purified Reverse-Transcriptase.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.69.8.5087-5094.1995
– volume: 82
  start-page: 3952
  year: 2008
  ident: ref16
  article-title: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.02660-07
– volume: 87
  start-page: 6024
  year: 1990
  ident: ref23
  article-title: Broad-Spectrum of Invivo Forward Mutations, Hypermutations, and Mutational Hotspots in A Retroviral Shuttle Vector After A Single Replication Cycle - Deletions and Deletions with Insertions.
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.87.16.6024
– volume: 78
  start-page: 13901
  year: 2004
  ident: ref47
  article-title: Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.78.24.13901-13910.2004
– volume: 6
  start-page: 945
  year: 1998
  ident: ref6
  article-title: HIV gp120: double lock strategy foils host defences.
  publication-title: Structure
  doi: 10.1016/S0969-2126(98)00096-3
– volume: 19
  start-page: 1865
  year: 2002
  ident: ref27
  article-title: Simulation study of the reliability and robustness of the statistical methods for detecting positive selection at single amino acid sites.
  publication-title: Molecular Biology and Evolution
  doi: 10.1093/oxfordjournals.molbev.a004010
– volume: 81
  start-page: 193
  year: 2007
  ident: ref44
  article-title: Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.01231-06
– volume: 22
  start-page: 1107
  year: 2005
  ident: ref56
  article-title: Bayes empirical Bayes inference of amino acid sites under positive selection.
  publication-title: Molecular Biology and Evolution
  doi: 10.1093/molbev/msi097
– start-page: 143
  year: 2002
  ident: ref65
  article-title: PCR-Sequence-Specific Primer Typing of HLA Class I and Class II Alleles
– volume: 80
  start-page: 1637
  year: 2006
  ident: ref46
  article-title: Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.80.4.1637-1644.2006
– volume: 10
  start-page: 97
  year: 2009
  ident: ref53
  article-title: Models of coding sequence evolution.
  publication-title: Briefings in Bioinformatics
  doi: 10.1093/bib/bbn049
– volume: 21
  start-page: 676
  year: 2005
  ident: ref18
  article-title: HyPhy: hypothesis testing using phylogenies.
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti079
– year: 2008
  ident: ref15
  article-title: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.
  publication-title: Proc Natl Acad Sci
– volume: 25
  start-page: 5026
  year: 2006
  ident: ref14
  article-title: Restraining the conformation of HIV-1 Gp120 by removing a flexible loop.
  publication-title: Embo Journal
  doi: 10.1038/sj.emboj.7601358
– volume: 4
  start-page: e12
  year: 2008
  ident: ref41
  article-title: Vaccination and timing influence SIV immune escape viral dynamics in vivo.
  publication-title: Plos Pathogens
  doi: 10.1371/journal.ppat.0040012
– volume: 80
  start-page: 4717
  year: 2006
  ident: ref64
  article-title: Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8(+) T-cell epitopes.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.80.10.4717-4728.2006
– start-page: 3
  year: 2008
  ident: ref25
  article-title: Identification and Optimal Definition of HIV-Derived Cytotoxic T Lymphocyte (CTL) Epitopes for the Study of CTL Escape, Functional Avidity and Viral Evolution
– volume: 81
  start-page: 115
  year: 2003
  ident: ref29
  article-title: Potential impact of recombination on sitewise approaches for detecting positive natural selection.
  publication-title: Genetical Research
  doi: 10.1017/S0016672303006128
– volume: 80
  start-page: 9586
  year: 2006
  ident: ref26
  article-title: Human immunodeficiency virus type 1 V1–V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.00141-06
– volume: 81
  start-page: 6187
  year: 2007
  ident: ref22
  article-title: Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.00239-07
– volume: 27
  start-page: 4779
  year: 2008
  ident: ref50
  article-title: Estimating selection pressures on HIV-1 using phylogenetic likelihood models.
  publication-title: Statistics in Medicine
  doi: 10.1002/sim.3192
– volume: 79
  start-page: 6523
  year: 2005
  ident: ref21
  article-title: Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.79.10.6523-6527.2005
– volume: 3
  start-page: 722
  year: 2005
  ident: ref32
  article-title: Mobile genetic elements: The agents of open source evolution.
  publication-title: Nature Reviews Microbiology
  doi: 10.1038/nrmicro1235
– volume: 102
  start-page: 14943
  year: 2005
  ident: ref9
  article-title: Antibody vs. HIV in a clash of evolutionary titans.
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.0505126102
– volume: 393
  start-page: 705
  year: 1998
  ident: ref12
  article-title: The antigenic structure of the HIV gp120 envelope glycoprotein.
  publication-title: Nature
  doi: 10.1038/31514
– volume: 23
  start-page: 1891
  year: 2006
  ident: ref30
  article-title: Automated phylogenetic detection of recombination using a genetic algorithm.
  publication-title: Molecular Biology and Evolution
  doi: 10.1093/molbev/msl051
– volume: 81
  start-page: 5418
  year: 2007
  ident: ref40
  article-title: In vivo fitness costs of different gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.02763-06
– volume: 407
  start-page: 386
  year: 2000
  ident: ref42
  article-title: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
  publication-title: Nature
  doi: 10.1038/35036559
– volume: 148
  start-page: 929
  year: 1998
  ident: ref51
  article-title: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene.
  publication-title: Genetics
  doi: 10.1093/genetics/148.3.929
– volume: 4(3)
  start-page: e1000033
  year: 2008
  ident: ref1
  article-title: Transmission of HIV-1CTL escape variants provides HLA-mismatched recipients with a survival advantage.
  publication-title: Plos Pathogens
  doi: 10.1371/journal.ppat.1000033
– volume: 79
  start-page: 13239
  year: 2005
  ident: ref45
  article-title: Selective escape from CD8(+) T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
  publication-title: Journal of Virology
  doi: 10.1128/JVI.79.21.13239-13249.2005
– volume: 57
  start-page: 212
  year: 2003
  ident: ref52
  article-title: Widespread adaptive evolution in the human immunodeficiency virus type 1 genome.
  publication-title: Journal of Molecular Evolution
  doi: 10.1007/s00239-003-2467-9
SSID ssj0041316
Score 2.3564868
Snippet The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced...
  The pattern of viral diversification in newly infected individuals provides information about the host environment and immune responses typically experienced...
SourceID plos
doaj
pubmedcentral
osti
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1000414
SubjectTerms Acquired immune deficiency syndrome
AIDS
Base Sequence
BASIC BIOLOGICAL SCIENCES
Cross-Sectional Studies
Cytidine Deaminase - metabolism
Cytokines
Development and progression
env Gene Products, Human Immunodeficiency Virus - genetics
Epitopes, T-Lymphocyte - genetics
Evolution & development
Evolution, Molecular
evolutionary immunology
Genes, Viral - physiology
Genetic aspects
Genetic diversity
Health aspects
HIV
HIV (Viruses)
HIV infection
HIV Infections - genetics
HIV Infections - virology
HIV-1
HIV-1 - genetics
Human immunodeficiency virus
Human immunodeficiency virus 1
Humans
Immune response
INDEL Mutation
Infectious Diseases/HIV Infection and AIDS
microbial mutation
Models, Genetic
Molecular Sequence Data
phylogenetic analysis
Phylogeny
Physiological aspects
Risk factors
sequence alignment
substitution mutation
T-Lymphocytes, Cytotoxic - virology
viral evolution
Viral proteins
Virology/Immune Evasion
Virology/Immunodeficiency Viruses
Virology/Vaccines
Virology/Virus Evolution and Symbiosis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9RAEF7kQPBF_N3YqosIvjQ22eyPxLdrabkKVlErfVt2N7taKMlh7oT-953ZJGcjlr74cpDb73LszGT3CzvzDSFvVKZUXQaeculFykWoUizfTFWF9MD4KovlYx9P5OKUfzgTZ9dafWFOWC8P3Btuz8nAPGw6JTOcs8xVmS2Eqsq64JVTyuPqC9vY-DLVr8GwMsemp9gUJ1WFlEPRXKHyvcFH75ZLg_LRCOaTTSlq929W6FkLjxoqn1603b9Y6N_JlNd2p6MH5P5AK-m8n85Dcsc3j8jdvtHk5WPSLY6_U_97CDN63lCPwsZ0TMVq3tMuNsTB0Zgau4aPXbqM6ptNR9sAWDy4R4Bpaor9c_BiN14Bi6R9vSUi558_7R8ePCGnR4ffDhbp0G4hdUqIVRqCsIWypgAKFlgITlRBZa4Ggihr6Wppchu4MOA9Y5yogVlkWZC-EpVVqAz3lMyatvFbhNbBF0YoWzvheG2FDS7PrA25dAVQOp6QYrS3doMWObbEuNDxgE3BO0lvN41e0oOXEpJufrXstThuwe-jKzdYVNKOX0B86SG-9G3xlZDXGAgatTIaTMb5YdZdp4-_nug5Q3k-INj5jaAvE9DbARRamKwzQwEEmAw1uCbInQkSnng3Gd7GoNTAkVDo12FGlINZS6xqZgnZwlgdLdLpHM-SRQlcNCGvxvjVeE_Mr2t8u-40ivqXwORuRkjFGPx3lpBnfbz_cUGFxZIM7q4mT8LE7tOR5vxnVDJnEqgRl8__h6O2yb3-pA-TUXfIbPVr7V8AYVzZl3FtuAJltGYf
  priority: 102
  providerName: Directory of Open Access Journals
Title HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC
URI https://www.ncbi.nlm.nih.gov/pubmed/19424423
https://www.proquest.com/docview/20668521
https://www.proquest.com/docview/67229110
https://www.osti.gov/servlets/purl/1627892
https://pubmed.ncbi.nlm.nih.gov/PMC2671846
https://doaj.org/article/c6f2e06182a4420c90b35798d349c77e
http://dx.doi.org/10.1371/journal.ppat.1000414
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: KQ8
  dateStart: 20050901
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: KQ8
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: DOA
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: ABDBF
  dateStart: 20050901
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: DIK
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: GX1
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: RPM
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: 7X7
  dateStart: 20050901
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1553-7374
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: BENPR
  dateStart: 20050901
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1553-7374
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0041316
  issn: 1553-7374
  databaseCode: M48
  dateStart: 20050901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9swEBdtymAvY9_12mVmjO2lLv7QRzwYIykp6aBZ6ZaRNyHLUlcIdhonY_3vdyc72Twa-mKwdZbx6ST97Lv7HSHvRChE3rM0oNywgDKbBpi-GYgU4YEyaejSx87HfDShX6ZsukPWjvZGgdWdn3ZYT2qymB3_vrn9DBP-k6vaIKL1TcfzuUJCaKSQou_nNwGWlkIXbFNnY5fswXYVo-mf042rARZxVx8V6-cEIhG0ya_b1nFr_3I0_5vFvFPCrESS1FlZ3QVY_4-7_GcjO31MHjUI1O_XJvOE7JjiKXlQ16S8fUaq0dkP3_xqLNK_LnyDHMj-Omqr-OhXrnYOtroo2hUcjvy5I-osKr-0IIs-fhRQRe5jqR08OXJnADj9OjUTJfsXXwfDk-dkcjr8fjIKmsoMgRaMLQNrWZaITCWA1mxsrWapFaHOAUvynOucqyizlCkYaKU0ywGEhKHlJmVpJpBE7gXpFGVh9omfW5MoJrJcM03zjGVWR2GW2YjrBNAf9Uiy1rfUDW05Vs-YSeeLE_D5UutN4ijJZpQ8Emzumte0HffID3AoN7JIuu0ulIsr2cxhqbmNDeCfXqwojUOdhlnCRNrLE5pqIYxH3qIhSKTVKDBu50qtqkqefRvLfoxMfoDFo61Cly2hD42QLeFltWpyJUBlSNfVkjxsScLioFvNB2iUEuAUcgJrDJ7S8NYcE6Bjj-yjra41UskI3c6sB7DVI2_W9iuxTwzFK0y5qiTy__cA9G2X4CKO4dmhR17W9v53CFLMq4yhd9GaCS29t1uK65-O9DzmgKIof3XvUw_Iw9rjh0Gph6SzXKzMawCOy6xLdsVUdMneYDi-uOy63y9dtxj8AXTWcPo
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIV+evolution+in+early+infection%3A+selection+pressures%2C+patterns+of+insertion+and+deletion%2C+and+the+impact+of+APOBEC&rft.jtitle=PLoS+pathogens&rft.au=Wood%2C+Natasha&rft.au=Bhattacharya%2C+Tanmoy&rft.au=Keele%2C+Brandon+F&rft.au=Giorgi%2C+Elena&rft.date=2009-05-01&rft.issn=1553-7374&rft.eissn=1553-7374&rft.volume=5&rft.issue=5&rft.spage=e1000414&rft_id=info:doi/10.1371%2Fjournal.ppat.1000414&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon